Bioverge Funds, Contraline II, LLC

New Filing
CIK: 0001952836·Investing·IDAHO·Filed: Nov 3, 2022
Total Offering

$150,000

Amount Sold

$124,500

Investors

11

First Sale

Oct 26, 2022

Offering Details

Type
Pooled Investment Fund
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Neil Bioverge Funds Management,LLC - Littman
Related Person

Company

Bioverge Funds, Contraline II, LLC

222 N 13TH ST

BOISE, ID, 83702

2086961262

SEC Filing

0001952836-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Bioverge Funds, Contraline II, LLC Form D Filing — $150,000 | FilingFlow